Myovant Sciences Ltd. at its 2022 Annual General Meeting of Shareholders held on October 21, 2022, approved the appointment of Shigeyuki Nishinaka as a director for a one-year term.
Myovant Sciences Ltd.
Equities
MYOV
BMG637AM1024
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
+22.56% | 46.4B | |
-1.51% | 41.75B | |
+48.83% | 41.37B | |
-3.42% | 29.71B | |
+10.08% | 26.01B | |
-19.17% | 19.52B | |
+29.16% | 12.43B | |
+0.23% | 12.18B | |
-0.35% | 12.13B |